CVS Health (CVS)
(Delayed Data from NYSE)
$56.11 USD
-0.83 (-1.46%)
Updated Sep 11, 2024 03:59 PM ET
After-Market: $56.07 -0.04 (-0.07%) 6:18 PM ET
4-Sell of 5 4
A Value D Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$56.11 USD
-0.83 (-1.46%)
Updated Sep 11, 2024 03:59 PM ET
After-Market: $56.07 -0.04 (-0.07%) 6:18 PM ET
4-Sell of 5 4
A Value D Growth F Momentum C VGM
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $52.96 in the latest trading session, marking a +1.01% move from the prior day.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $53.90, marking a -0.59% move from the previous day.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $54.18, marking a +0.22% move from the previous day.
Amazon (AMZN) Stock Looks Like a Buy Heading into Q1 2019 Earnings
by Benjamin Rains
Shares of Amazon (AMZN) have outpaced the market in 2019, up 21% against the S&P's 15% jump. Despite the strong start, Amazon stock rests over 11% below its 52-week high. So, let's take a look at why Amazon appears to be a buy right now heading into its Q1 2019 earnings release .
The Zacks Analyst Blog Highlights: Walgreens, Amazon and CVS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Walgreens, Amazon and CVS
Aging Demography, Consolidation Brighten HMO Industry Outlook
by Sapna Bagaria
Increasing retirement population, industry consolidation, growth of ancillary business and easing of regulatory changes promise solid growth for the HMO industry.
What to Expect from CVS' Q1 Earnings After Walgreens Stock Tanks
by Benjamin Rains
CVS Health (CVS) stock has been down in the dumps for years and shares have already fallen 20% in 2019 even as the broader market booms. Now, after Walgreens Boots Alliance's (WBA) massive one-day, post-earnings selloff Tuesday, it's time to see what investors should expect from CVS.
Walgreens Has Biggest One-Day Loss in 5 year: What Does This Mean For Pharmacies?
by Daniel Laboe
Walgreens Boots Alliance (WBA) dropped over 12% today taking the price down to a low of $55, the lowest the stock has traded at since 2014. WBA???s tumble was initiated by worse than expected earnings, and a full year EPS guidance adjustment which would make them flat for 2019.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $54.19, marking a +0.48% move from the previous day.
Buy Walgreens (WBA) Stock Ahead of Q2 Earnings, Before CBD Push?
by Benjamin Rains
Shares of Walgreens Boots Alliance, Inc. (WBA) have fallen roughly 9% this year, which stands in contrast to the market's nearly 13% climb and its industry's 4.5% average gains. But is it time to buy WBA stock ahead of earnings?
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $55.50, marking a +1% move from the previous day.
Better Buy Amid Tech Diversification: Apple (AAPL) vs. Amazon (AMZN) Stock
by Benjamin Rains
Apple (AAPL) and Amazon (AMZN) are two of the largest companies on the planet. The tech powers have reshaped industries and changed the way millions of people function on a daily basis. But today, Apple and Amazon face possible transition periods as they try to expand their offerings to drive growth. So which stock, AAPL or AMZN, is a better buy?
Why Is CVS Health (CVS) Down 7.9% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $56.16, moving -1.63% from the previous trading session.
Amazon's HSA & FSA Payment Option to Boost Pharma Initiatives
by Zacks Equity Research
Amazon (AMZN) rolls out payment options via HSA and FSA for medical purchases made on its online platform which is likely to strengthen its healthcare market presence.
Pivotal Software (PVTL) Q4 Loss Narrows, Revenues Up Y/Y
by Zacks Equity Research
Pivotal Software (PVTL) fourth-quarter fiscal 2019 results benefit from growth in subscription revenues on the back of increase in customers and services adoption.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $55.88 in the latest trading session, marking a -1.22% move from the prior day.
Buy Amazon (AMZN) Stock on Earnings Growth & E-commerce Dominance?
by Benjamin Rains
Amazon (AMZN) shares have climbed roughly 13% to start the year, which tops the market's comeback, but falls way behind fellow FAANG giants Facebook (FB) and Netflix (NFLX). Therefore, Amazon stock still rests over 17% below its 52-week high.
CVS Health Stock Jumps on Bullish Coverage: Time to Buy?
by Benjamin Rains
Shares of CVS Health (CVS) surged over 4% through mid-afternoon trading Wednesday on the back of a bullish call from Bernstein analysts. The drugstore chain is also coming off a stronger-than-expected fourth quarter. So, is now the time to buy CVS stock?
New Strong Sell Stocks for March 12th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $52.93, marking a +1.08% move from the previous day.
Buy Target (TGT) Stock After Q4 Earnings on E-Commerce Growth?
by Benjamin Rains
Shares of Target (TGT) surged over 4.5% Tuesday after it reported its fourth quarter financial results before the opening bell. The climb helped continue the retail power's strong 2019. So is now the time to buy shares of TGT as it proves that its e-commerce investments have paid off.
What to Expect from Kroger (KR) Earnings as Amazon Expands Grocery Business
by Benjamin Rains
Let's see what to expect from Kroger's fourth-quarter financial results that are due out Thursday, with Amazon (AMZN) set to roll out its own branded grocery store-style offerings.
The Zacks Analyst Blog Highlights: McDonald's, CVS Health, Celgene, Coca-Cola and Agilent
by Zacks Equity Research
The Zacks Analyst Blog Highlights: McDonald's, CVS Health, Celgene, Coca-Cola and Agilent
CVS Health Rides on Aetna Synergy, PBM Selling Season Modest
by Zacks Equity Research
With regard to its 2019 PBM selling season, CVS Health (CVS) notes that the net benefits from this selling season are expected to be modest on Anthem-related headwinds.